- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 14/33 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant de bactéries provenant de Clostridium (G)
Détention brevets de la classe C07K 14/33
Brevets de cette classe: 786
Historique des publications depuis 10 ans
|
59
|
51
|
61
|
70
|
69
|
71
|
58
|
54
|
47
|
16
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Allergan, Inc. | 2361 |
57 |
| MERZ PHARMA GmbH & CO. KGaA | 618 |
37 |
| Ipsen Biopharm Limited | 261 |
34 |
| President and Fellows of Harvard College | 5952 |
26 |
| Glaxosmithkline Biologicals S.A. | 1635 |
22 |
| Children's Medical Center Corporation | 1853 |
22 |
| Ipsen Bioinnovation Limited | 41 |
19 |
| Wisconsin Alumni Research Foundation | 3864 |
18 |
| The Regents of the University of California | 19839 |
15 |
| Pfizer Inc. | 3370 |
13 |
| Wyeth LLC | 653 |
13 |
| Revance Therapeutics, Inc. | 147 |
12 |
| Daewoong Co., Ltd. | 64 |
11 |
| Valneva Austria GmbH | 114 |
11 |
| Massachusetts Institute of Technology | 10019 |
10 |
| The Governors of the University of Alberta | 864 |
7 |
| Osaka University | 3367 |
7 |
| University of Guelph | 356 |
7 |
| Vaxiion Therapeutics, LLC | 20 |
7 |
| Jetema Co., Ltd. | 56 |
7 |
| Autres propriétaires | 431 |